{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:27:21Z","timestamp":1782253641054,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.biopha.2016.02.028","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T09:00:42Z","timestamp":1458291642000},"page":"115-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["ABCB1 variants confer susceptibility to primary open-angle glaucoma and predict individual differences to latanoprost treatment"],"prefix":"10.1016","volume":"80","author":[{"given":"Hai","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan-Chu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.02.028_bib0005","first-page":"330","article-title":"A 4-year retrospective study of add-on therapy to the fixed combination of dorzolamide\/timolol for the treatment of POAG","volume":"7","author":"Hartleben-Matkin","year":"2014","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2016.02.028_bib0010","first-page":"1548","article-title":"Comprehensive analysis of myocilin variants in east Indian POAG patients","volume":"18","author":"Banerjee","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.biopha.2016.02.028_bib0015","doi-asserted-by":"crossref","first-page":"182021","DOI":"10.1155\/2013\/182021","article-title":"Relationship among photopic negative response, retinal nerve fiber layer thickness, and visual field between normal and POAG eyes","volume":"2013","author":"Shen","year":"2013","journal-title":"ISRN Ophthalmol."},{"issue":"4","key":"10.1016\/j.biopha.2016.02.028_bib0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1442-9071.2012.02773.x","article-title":"Definition of glaucoma: clinical and experimental concepts","volume":"40","author":"Casson","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.biopha.2016.02.028_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/13816810.2012.736592","article-title":"Role of rs1533428 and rs12994401 in patients with primary open angle glaucoma in an European population","volume":"34","author":"Bachernegg","year":"2013","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.biopha.2016.02.028_bib0030","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1016\/j.actbio.2014.05.031","article-title":"Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension","volume":"10","author":"Cheng","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2016.02.028_bib0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/1874364101408010060","article-title":"Influence of latanoprost on retinal microcirculation in glaucoma","volume":"8","author":"Kremmer","year":"2014","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.biopha.2016.02.028_bib0040","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2147\/OPTH.S13777","article-title":"Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension","volume":"6","author":"Pacella","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.biopha.2016.02.028_bib0045","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1755-3768.2009.01683.x","article-title":"Alterations in anterior chamber depth in primary open-angle glaucoma patients during latanoprost therapy","volume":"89","author":"Cankaya","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.biopha.2016.02.028_bib0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.preteyeres.2013.09.001","article-title":"The vast complexity of primary open angle glaucoma: disease genes, risks, molecular mechanisms and pathobiology","volume":"37","author":"Janssen","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biopha.2016.02.028_bib0055","first-page":"1960","article-title":"Lack of association of SNP rs4236601 near CAV1 and CAV2 with POAG in a Saudi cohort","volume":"18","author":"Abu-Amero","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.biopha.2016.02.028_bib0060","doi-asserted-by":"crossref","first-page":"e103063","DOI":"10.1371\/journal.pone.0103063","article-title":"MTHFR C677T predisposes to POAG but not to PACG in a North Indian population: a case control study","volume":"9","author":"Gupta","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2016.02.028_bib0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.drup.2012.03.001","article-title":"Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1","volume":"15","author":"Gillet","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.biopha.2016.02.028_bib0070","doi-asserted-by":"crossref","first-page":"e82463","DOI":"10.1371\/journal.pone.0082463","article-title":"Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1)","volume":"8","author":"Chufan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.02.028_bib0075","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.pnpbp.2009.07.016","article-title":"Association between ABCB1C3435T polymorphism and increased risk of cannabis dependence","volume":"33","author":"Benyamina","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.biopha.2016.02.028_bib0080","doi-asserted-by":"crossref","first-page":"e59419","DOI":"10.1371\/journal.pone.0059419","article-title":"Functional impact of ABCB1 variants on interactions between P-glycoprotein and methadone","volume":"8","author":"Hung","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.02.028_bib0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5607\/en.2012.21.4.164","article-title":"Association between ABCB1 polymorphisms and ischemic stroke in korean population","volume":"21","author":"Kim","year":"2012","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.biopha.2016.02.028_bib0090","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/FTD.0b013e318288f158","article-title":"Putative association of ABCB1 2677G>T\/A with oxycodone-induced central nervous system depression in breastfeeding mothers","volume":"35","author":"Lam","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.biopha.2016.02.028_bib0095","doi-asserted-by":"crossref","first-page":"7599","DOI":"10.1007\/s13277-015-3403-5","article-title":"ABCB1 polymorphisms correlate with susceptibility to adult acute leukemia and response to high-dose methotrexate","volume":"36","author":"Ma","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2016.02.028_bib0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1755-148X.2011.00841.x","article-title":"ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity","volume":"24","author":"Landreville","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"issue":"20","key":"10.1016\/j.biopha.2016.02.028_bib0105","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.biopha.2016.02.028_bib0110","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ophtha.2008.12.037","article-title":"Joint LSTF. LASIK world literature review: quality of life and patient satisfaction","volume":"116","author":"Solomon","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2016.02.028_bib0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jamaophthalmol.2014.4908","article-title":"Patient-reported vision-related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma","volume":"133","author":"Cheng","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.biopha.2016.02.028_bib0120","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jcrs.2004.09.036","article-title":"Visual field changes after laser in situ keratomileusis","volume":"31","author":"Brown","year":"2005","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.biopha.2016.02.028_bib0125","doi-asserted-by":"crossref","first-page":"e114489","DOI":"10.1371\/journal.pone.0114489","article-title":"Postoperative vision-related quality of life in macula-off rhegmatogenous retinal detachment patients and its relation to visual function","volume":"9","author":"van de Put","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.02.028_bib0130","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1167\/iovs.13-12128","article-title":"Gene expression profile in human trabecular meshwork from patients with primary open-angle glaucoma","volume":"54","author":"Liu","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2016.02.028_bib0135","doi-asserted-by":"crossref","first-page":"e58657","DOI":"10.1371\/journal.pone.0058657","article-title":"A genome-wide association study for primary open angle glaucoma and macular degeneration reveals novel Loci","volume":"8","author":"Scheetz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.02.028_bib0140","doi-asserted-by":"crossref","first-page":"e1001306","DOI":"10.1371\/journal.pgen.1001306","article-title":"Mapping of the disease locus and identification of ADAMTS10 as a candidate gene in a canine model of primary open angle glaucoma","volume":"7","author":"Kuchtey","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biopha.2016.02.028_bib0145","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1167\/iovs.10-6339","article-title":"Genetic variants associated with optic nerve vertical cup-to-disc ratio are risk factors for primary open angle glaucoma in a US Caucasian population","volume":"52","author":"Fan","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2016.02.028_bib0150","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/hmg\/ddr120","article-title":"Common genetic variants associated with open-angle glaucoma","volume":"20","author":"Ramdas","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2016.02.028_bib0155","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/gtmb.2012.0019","article-title":"CYP2C9 and VKORC1 polymorphisms are differently distributed in the Brazilian population according to self-declared ethnicity or genetic ancestry","volume":"16","author":"Soares","year":"2012","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.biopha.2016.02.028_bib0160","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1182\/blood-2010-07-296954","article-title":"Polymorphisms in the multidrug resistance gene MDR1 (ABCB1) predict for molecular resistance in patients with newly diagnosed chronic myeloid leukemia receiving high-dose imatinib","volume":"116","author":"Deenik","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2016.02.028_bib0165","doi-asserted-by":"crossref","first-page":"e32784","DOI":"10.1371\/journal.pone.0032784","article-title":"A comprehensive investigation on common polymorphisms in the MDR1\/ABCB1 transporter gene and susceptibility to colorectal cancer","volume":"7","author":"Campa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.02.028_bib0170","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00384-010-0961-2","article-title":"ABCB1\/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer","volume":"25","author":"Balcerczak","year":"2010","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.biopha.2016.02.028_bib0175","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.canep.2013.04.012","article-title":"Influence of ABCB1 genetic variants in breast cancer treatment outcomes","volume":"37","author":"Chaturvedi","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.biopha.2016.02.028_bib0180","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/ng.3078","article-title":"Common variants near ABCA1 and in PMM2 are associated with primary open-angle glaucoma","volume":"46","author":"Chen","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2016.02.028_bib0185","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/jop.2011.0165","article-title":"A double-masked randomized crossover study comparing the effect of latanoprost\/timolol and brimonidine\/timolol fixed combination on intraocular pressure and ocular blood flow in patients with primary open-angle glaucoma or ocular hypertension","volume":"28","author":"Hommer","year":"2012","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2016.02.028_bib0190","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/bjophthalmol-2012-303026","article-title":"Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension","volume":"97","author":"Konstas","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2016.02.028_bib0195","first-page":"219","article-title":"Safety and efficacy of a fixed versus unfixed brinzolamide\/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension","volume":"8","author":"Ono","year":"2014","journal-title":"Clini. Ophthalmol."},{"key":"10.1016\/j.biopha.2016.02.028_bib0200","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bjophthalmol-2013-304267","article-title":"Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene, and response to latanoprost in patients with glaucoma and ocular hypertension","volume":"98","author":"Sakurai","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2016.02.028_bib0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00228-014-1769-8","article-title":"Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients","volume":"71","author":"Gao","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215301396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215301396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:00:43Z","timestamp":1760094043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215301396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":41,"alternative-id":["S0753332215301396"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.02.028","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ABCB1 variants confer susceptibility to primary open-angle glaucoma and predict individual differences to latanoprost treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}